Karina Raimundo

1.8k total citations
59 papers, 1.2k citations indexed

About

Karina Raimundo is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Karina Raimundo has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 13 papers in Pathology and Forensic Medicine and 13 papers in Hematology. Recurrent topics in Karina Raimundo's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Hemophilia Treatment and Research (11 papers) and Urticaria and Related Conditions (7 papers). Karina Raimundo is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Hemophilia Treatment and Research (11 papers) and Urticaria and Related Conditions (7 papers). Karina Raimundo collaborates with scholars based in United States, Switzerland and United Kingdom. Karina Raimundo's co-authors include Michael S. Broder, Eunice Chang, Amanda M. Kong, Ashley L. Cole, James L. Zazzali, Jeffrey J. Swigris, Evgeniya Antonova, Aryeh Fischer, John L. Stauffer and Theodore A. Omachi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Karina Raimundo

58 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karina Raimundo United States 18 718 409 344 279 153 59 1.2k
Ruchika Goel India 19 649 0.9× 89 0.2× 345 1.0× 58 0.2× 82 0.5× 63 1.1k
Peer Aries Germany 13 374 0.5× 168 0.4× 319 0.9× 65 0.2× 109 0.7× 51 707
Michel Pavic France 14 272 0.4× 195 0.5× 71 0.2× 88 0.3× 105 0.7× 96 901
James N. Butera United States 20 90 0.1× 154 0.4× 59 0.2× 545 2.0× 165 1.1× 55 1.2k
Bruno Guedes Baldi Brazil 17 502 0.7× 344 0.8× 135 0.4× 83 0.3× 66 0.4× 83 813
J Devlin United Kingdom 8 251 0.3× 179 0.4× 571 1.7× 105 0.4× 49 0.3× 13 875
Mohammed A. Omair Saudi Arabia 13 87 0.1× 47 0.1× 245 0.7× 234 0.8× 39 0.3× 86 662
L. Levin United States 12 135 0.2× 131 0.3× 72 0.2× 31 0.1× 61 0.4× 18 702
Béatrice André Belgium 9 136 0.2× 42 0.1× 387 1.1× 147 0.5× 15 0.1× 21 751
Salih Pay Türkiye 19 143 0.2× 32 0.1× 420 1.2× 114 0.4× 23 0.2× 68 992

Countries citing papers authored by Karina Raimundo

Since Specialization
Citations

This map shows the geographic impact of Karina Raimundo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karina Raimundo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karina Raimundo more than expected).

Fields of papers citing papers by Karina Raimundo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karina Raimundo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karina Raimundo. The network helps show where Karina Raimundo may publish in the future.

Co-authorship network of co-authors of Karina Raimundo

This figure shows the co-authorship network connecting the top 25 collaborators of Karina Raimundo. A scholar is included among the top collaborators of Karina Raimundo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karina Raimundo. Karina Raimundo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Mohleen, et al.. (2024). Impact of Pirfenidone on Patient-Reported Outcomes in Patients With Idiopathic Pulmonary Fibrosis From the Pulmonary Fibrosis Foundation Patient Registry. SHILAP Revista de lepidopterología. 2(4). 100082–100082. 1 indexed citations
2.
Patel, Anisha M., et al.. (2021). Real-world treatment, clinical outcomes and healthcare resource utilization among persons with hemophilia A by age. Journal of Comparative Effectiveness Research. 10(15). 1121–1131. 6 indexed citations
3.
Patel, Anisha M., et al.. (2020). Assessing patient and caregiver preferences for treatment of haemophilia A: A discrete choice experiment. Haemophilia. 27(4). e479–e483. 4 indexed citations
4.
Yohrling, George J., et al.. (2020). Prevalence of Huntington’s Disease in the US (954). Neurology. 94(15_supplement). 9 indexed citations
5.
Swigris, Jeffrey J., David Andrae, Mary Beth Scholand, et al.. (2020). Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire. American Journal of Respiratory and Critical Care Medicine. 202(12). 1689–1697. 28 indexed citations
6.
Raimundo, Karina, et al.. (2020). Patient and Physician Perspectives on the Care and Assistance Needs in Huntington’s Disease (HD) (946). Neurology. 94(15_supplement). 1 indexed citations
7.
Haselkorn, Tmirah, Susan L. Limb, John L. Stauffer, et al.. (2018). Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. Pulmonary Therapy. 4(1). 103–114. 3 indexed citations
8.
Ley, Brett, Jeffrey J. Swigris, John L. Stauffer, et al.. (2017). Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 196(6). 756–761. 131 indexed citations
9.
Fischer, Aryeh, Amanda M. Kong, Jeffrey J. Swigris, Ashley L. Cole, & Karina Raimundo. (2017). All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement. The Journal of Rheumatology. 45(2). 235–241. 33 indexed citations
10.
Pérez, Evans R. Fernández, et al.. (2017). Epidemiology of Hypersensitivity Pneumonitis among an Insured Population in the United States: A Claims-based Cohort Analysis. Annals of the American Thoracic Society. 15(4). 460–469. 123 indexed citations
11.
Raimundo, Karina, Eunice Chang, Michael S. Broder, et al.. (2016). Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study. BMC Pulmonary Medicine. 16(1). 2–2. 76 indexed citations
12.
Zazzali, James L., Allen P. Kaplan, Marcus Maurer, et al.. (2016). Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies. Annals of Allergy Asthma & Immunology. 117(4). 370–377.e1. 20 indexed citations
13.
Raimundo, Karina, Eunice Chang, Michael S. Broder, & James L. Zazzali. (2015). In-Hospital Length of Stay and Mortality for Patients With Idiopathic Pulmonary Fibrosis (IPF) in the US. CHEST Journal. 148(4). 402A–402A. 1 indexed citations
14.
Sawicki, Gregory S., et al.. (2015). Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients. Journal of Cystic Fibrosis. 14(6). 777–783. 27 indexed citations
15.
Cherepanov, Dasha, Karina Raimundo, Eunice Chang, et al.. (2015). Validation of an ICD-9–based claims algorithm for identifying patients with chronic idiopathic/spontaneous urticaria. Annals of Allergy Asthma & Immunology. 114(5). 393–398. 25 indexed citations
16.
Raimundo, Karina, Iftikhar Hussain, Syed M. Rehman, et al.. (2014). Validation Of An Icd-9-Based Claims Algorithm For Identifying Patients With Chronic Idiopathic/ Spontaneous Urticaria. Value in Health. 17(3). A283–A283. 1 indexed citations
17.
18.
Raimundo, Karina, et al.. (2013). Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS–Kaposi’s sarcoma. Journal of Medical Economics. 16(5). 606–613. 11 indexed citations
19.
Brandes, David, Karina Raimundo, Neetu Agashivala, & Edward Kim. (2013). Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis. Journal of Medical Economics. 16(4). 547–551. 11 indexed citations
20.
Augustovski, Federico, Jorge Díaz, Marcos Bosi Ferraz, et al.. (2012). Status Update of the Reimbursement Review Environment in the Public Sector across Four Latin American Countries. Value in Health Regional Issues. 1(2). 223–227. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruchika Goel Breakdown of academic impact, for papers by Peer Aries Breakdown of academic impact, for papers by Michel Pavic Breakdown of academic impact, for papers by James N. Butera Breakdown of academic impact, for papers by Bruno Guedes Baldi Breakdown of academic impact, for papers by J Devlin Breakdown of academic impact, for papers by Mohammed A. Omair Breakdown of academic impact, for papers by L. Levin Breakdown of academic impact, for papers by Béatrice André Breakdown of academic impact, for papers by Salih Pay
Rankless by CCL
2026